{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:01:02Z","timestamp":1792627262541,"version":"4.5.0"},"reference-count":207,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["RGP2\/399\/45"],"award-info":[{"award-number":["RGP2\/399\/45"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.isci.2024.111677","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T04:09:32Z","timestamp":1735013372000},"page":"111677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["The burden of group A Streptococcus (GAS) infections: The challenge continues in the twenty-first century"],"prefix":"10.1016","volume":"28","author":[{"given":"Aswin","family":"Thacharodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saqib","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avadh","family":"Vithlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawfeeq","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Kavish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole-Mae","family":"Geli Blacknell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9529-3306","authenticated-orcid":false,"given":"Arivalagan","family":"Pugazhendhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.111677_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s12879-020-05241-x","article-title":"Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China","volume":"20","author":"Li","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib2","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1128\/JCM.00301-15","article-title":"Streptococcus pyogenes emm types and clusters during a 7-year period (2007 to 2013) in pharyngeal and nonpharyngeal pediatric isolates","volume":"53","author":"Koutouzi","year":"2015","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/pathogens10020248","article-title":"A review of Streptococcus pyogenes: public health risk factors, prevention and control","volume":"10","author":"Avire","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.isci.2024.111677_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/d41586-022-04403-y","article-title":"Why is strep A surging\u2014and how worried are scientists?","volume":"612","author":"Ledford","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.111677_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1473-3099(23)00050-6","article-title":"Increase in paediatric group A streptococcal infections","volume":"23","author":"Pigeolet","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib7","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/S2213-2600(22)00507-0","article-title":"Rise in group A streptococcal infections in England","volume":"11","author":"Venkatesan","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.isci.2024.111677_bib8","series-title":"Strep A treatment, working for now","author":"Microbe","year":"2022"},{"key":"10.1016\/j.isci.2024.111677_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00138-6","article-title":"Thoughts on group A streptococci","volume":"4","author":"Yu","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.isci.2024.111677_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41579-023-00939-6","article-title":"Author correction: pathogenesis, epidemiology and control of group A streptococcus infection","volume":"21","author":"Brouwer","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib11","series-title":"M protein and other surface proteins on streptococci","author":"Fischetti","year":"2016"},{"key":"10.1016\/j.isci.2024.111677_bib12","series-title":"Streptococcus pyogenes: basic biology to clinical manifestations","author":"Ferretti","year":"2016"},{"key":"10.1016\/j.isci.2024.111677_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.760255","article-title":"Antibiotic treatment, mechanisms for failure, and adjunctive therapies for infections by group A Streptococcus","volume":"12","author":"Johnson","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib14","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JCM.00422-08","article-title":"Epidemiology of severe Streptococcus pyogenes disease in Europe","volume":"46","author":"Lamagni","year":"2008","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib15","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/S2666-5247(23)00318-X","article-title":"Global Streptococcus pyogenes strain diversity, disease associations, and implications for vaccine development: a systematic review","volume":"5","author":"Smeesters","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.isci.2024.111677_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/QCO.0000000000001064","article-title":"Chains of misery: surging invasive group A streptococcal disease","volume":"37","author":"Davis","year":"2024","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1473-3099(17)30694-1","article-title":"Scarlet fever makes a comeback","volume":"18","author":"Walker","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/infdis\/jis362","article-title":"Molecular characterization of the 2011 Hong Kong scarlet fever outbreak","volume":"206","author":"Tse","year":"2012","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijid.2020.06.053","article-title":"Increase of emm1 isolates among group A Streptococcus strains causing scarlet fever in Shanghai, China","volume":"98","author":"Chen","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jmii.2024.01.004","article-title":"Detection of toxigenic M1UK lineage group A Streptococcus clones in Taiwan","volume":"57","author":"Chiang-Ni","year":"2024","journal-title":"J.\u00a0Microbiol. Immunol. Infect."},{"key":"10.1016\/j.isci.2024.111677_bib21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1473-3099(20)30279-6","article-title":"M1UK lineage in invasive group A streptococcus isolates from the USA","volume":"20","author":"Li","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib22","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41467-023-36717-4","article-title":"Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA","volume":"14","author":"Davies","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.111677_bib23","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.36.2300427","article-title":"Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1UK and diverse emm12 isolates, Portugal, September 2022 to May 2023","volume":"28","author":"Gouveia","year":"2023","journal-title":"Euro Surveill."},{"key":"10.1016\/j.isci.2024.111677_bib24","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.1.2200942","article-title":"Increase in invasive group A streptococcal infection notifications, England, 2022","volume":"28","author":"Guy","year":"2023","journal-title":"Euro Surveill."},{"key":"10.1016\/j.isci.2024.111677_bib25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/JS9.0000000000000232","article-title":"Rising global incidence of invasive group A streptococcus infection and scarlet fever in the COVID-19 era\u2013our knowledge thus far","volume":"109","author":"Mohapatra","year":"2023","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.isci.2024.111677_bib26","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S2352-4642(22)00374-1","article-title":"Paediatric group A streptococcal disease in England from October to December, 2022","volume":"7","author":"Ladhani","year":"2023","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.isci.2024.111677_bib27","article-title":"Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges","volume":"41","author":"Abo","year":"2023","journal-title":"Lancet Reg. Health. Western Pacific"},{"key":"10.1016\/j.isci.2024.111677_bib28","article-title":"Trends in pediatric ambulatory community acquired infections before and during COVID-19 pandemic: A prospective multicentric surveillance study in France","volume":"22","author":"Cohen","year":"2022","journal-title":"Lancet Reg. Health. Eur."},{"key":"10.1016\/j.isci.2024.111677_bib29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/ijmm.IJMM_18_107","article-title":"Trends in antimicrobial resistance patterns of Group A streptococci, molecular basis and implications","volume":"36","author":"Abraham","year":"2018","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib30","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ajpath.2022.06.011","article-title":"A chimeric penicillin binding protein 2X significantly decreases in\u00a0vitro beta-lactam susceptibility and increases in\u00a0vivo fitness of Streptococcus pyogenes","volume":"192","author":"Olsen","year":"2022","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.isci.2024.111677_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cid\/ciz1000","article-title":"Streptococcus pyogenes pbp2x mutation confers reduced susceptibility to \u03b2-lactam antibiotics","volume":"71","author":"Vannice","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib32","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jmii.2020.08.019","article-title":"Emergence of macrolide-resistant Streptococcus pyogenes emm12 in southern Taiwan from 2000 to 2019","volume":"54","author":"Tsai","year":"2021","journal-title":"J.\u00a0Microbiol. Immunol. Infect."},{"key":"10.1016\/j.isci.2024.111677_bib33","series-title":"Open Forum Infectious Diseases","first-page":"S569","article-title":"Increased Prevalence of Group A Streptococcus (GAS) High Level Macrolide Resistance During the COVID-19 Pandemic","author":"Patel","year":"2022"},{"key":"10.1016\/j.isci.2024.111677_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/acsinfecdis.7b00251","article-title":"Antibiotic resistance ABC-F proteins: bringing target protection into the limelight","volume":"4","author":"Sharkey","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fmicb.2015.00026","article-title":"Composite mobile genetic elements disseminating macrolide resistance in Streptococcus pneumoniae","volume":"6","author":"Chancey","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib36","doi-asserted-by":"crossref","first-page":"e1266","DOI":"10.1093\/cid\/ciac468","article-title":"Continued Increase of Erythromycin Nonsusceptibility and Clindamycin Nonsusceptibility Among Invasive Group A Streptococci Driven by Genomic Clusters, United States, 2018\u20132019","volume":"76","author":"Li","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib37","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/cid\/ciab575","article-title":"Patterns of antibiotic nonsusceptibility among invasive group A Streptococcus infections\u2014United States, 2006\u20132017","volume":"73","author":"Fay","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41579-023-00865-7","article-title":"Pathogenesis, epidemiology and control of Group A Streptococcus infection","volume":"21","author":"Brouwer","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib39","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3389\/fmicb.2018.01670","article-title":"Type M resistance to macrolides is due to a two-gene efflux transport system of the ATP-binding cassette (ABC) superfamily","volume":"9","author":"Iannelli","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib40","series-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]","article-title":"Mechanisms of Streptococcus pyogenes Antibiotic Resistance","author":"Cattoir","year":"2022"},{"key":"10.1016\/j.isci.2024.111677_bib41","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.3390\/ijms13044484","article-title":"Biochemistry of bacterial multidrug efflux pumps","volume":"13","author":"Kumar","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.111677_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00007-19","article-title":"Transferable mechanisms of quinolone resistance from 1998 onward","volume":"32","author":"Ruiz","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.isci.2024.111677_bib43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jiac.2019.10.004","article-title":"Molecular epidemiology, antimicrobial susceptibility, and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes in Japan","volume":"26","author":"Tatara","year":"2020","journal-title":"J.\u00a0Infect. Chemother."},{"key":"10.1016\/j.isci.2024.111677_bib44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1099\/jmm.0.001158","article-title":"Changes in epidemiologic characteristics and antimicrobial resistance of Streptococcus pyogenes isolated over 10 years from Japanese children with pharyngotonsillitis","volume":"69","author":"Ubukata","year":"2020","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib45","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.2147\/IDR.S279157","article-title":"Beta-haemolytic group A, C and G streptococcal infections in southern Hungary: a 10-year population-based retrospective survey (2008\u20132017) and a review of the literature","volume":"13","author":"Gajd\u00e1cs","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.isci.2024.111677_bib46","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3389\/fmicb.2018.00542","article-title":"Identification and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes clones harboring tetracycline and macrolide resistance in Shanghai, China","volume":"9","author":"Shen","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01422-17","article-title":"Population and whole genome sequence based characterization of invasive group A streptococci recovered in the United States during 2015","volume":"8","author":"Chochua","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.isci.2024.111677_bib48","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1128\/AAC.01284-12","article-title":"First detection of trimethoprim resistance determinant dfrG in Streptococcus pyogenes clinical isolates in India","volume":"56","author":"Bergmann","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2024.111677_bib49","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3389\/fmicb.2020.00797","article-title":"Emerging threat of antimicrobial resistance in \u03b2-hemolytic streptococci","volume":"11","author":"Oppegaard","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib50","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.5001\/omj.2020.79","article-title":"Group A Streptococcus antibiotic resistance in Iranian children: A meta-analysis","volume":"36","author":"Khademi","year":"2021","journal-title":"Oman Med. J."},{"key":"10.1016\/j.isci.2024.111677_bib51","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1038\/s41467-022-34243-3","article-title":"Host-dependent resistance of Group A Streptococcus to sulfamethoxazole mediated by a horizontally-acquired reduced folate transporter","volume":"13","author":"Rodrigo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.111677_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248201","article-title":"Improved transformation efficiency of group A Streptococcus by inactivation of a type I restriction modification system","volume":"16","author":"Finn","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.111677_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.21775\/cimb.032.123","article-title":"Mobile genetic elements in streptococci","volume":"32","author":"Lu","year":"2019","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.isci.2024.111677_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of NF-\u03baB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.isci.2024.111677_bib55","doi-asserted-by":"crossref","first-page":"19879","DOI":"10.1074\/jbc.M802848200","article-title":"Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9","volume":"283","author":"Gratz","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.111677_bib56","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2353\/ajpath.2010.090422","article-title":"Aberrant inflammatory response to Streptococcus pyogenes in mice lacking myeloid differentiation factor 88","volume":"176","author":"Loof","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.isci.2024.111677_bib57","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/sj.emboj.7601002","article-title":"Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis","volume":"25","author":"Nishitani","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.isci.2024.111677_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0021-2018","article-title":"Group A Streptococcus-mediated host cell Signaling","volume":"7","author":"Pancholi","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2024.111677_bib59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1189\/jlb.4MR0617-227RR","article-title":"Group A streptococcal pharyngitis: Immune responses involved in bacterial clearance and GAS-associated immunopathologies","volume":"103","author":"Soderholm","year":"2018","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.isci.2024.111677_bib60","first-page":"3070","article-title":"Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation","volume":"111","author":"von K\u00f6ckritz-Blickwede","year":"2008","journal-title":"Blood J. Am. Soci. Hematol."},{"key":"10.1016\/j.isci.2024.111677_bib61","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1086\/523647","article-title":"The contribution of dendritic cells to host defenses against Streptococcus pyogenes","volume":"196","author":"Loof","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/acs.jmedchem.0c01307","article-title":"Strategies for targeting the NLRP3 inflammasome in the clinical and preclinical space","volume":"64","author":"Schwaid","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.isci.2024.111677_bib63","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41564-017-0005-6","article-title":"Group A streptococcal M protein activates the NLRP3 inflammasome","volume":"2","author":"Valderrama","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib64","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.111677_bib65","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.isci.2024.111677_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003394","article-title":"Streptolysin O and its co-toxin NAD-glycohydrolase protect group A Streptococcus from Xenophagic killing","volume":"9","author":"O'Seaghdha","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2024.111677_bib67","doi-asserted-by":"crossref","first-page":"e0077124","DOI":"10.1128\/mbio.00771-24","article-title":"Capsule-deficient group A Streptococcus evades autophagy-mediated killing in macrophages","volume":"15","author":"Shi","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.isci.2024.111677_bib68","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1086\/379050","article-title":"Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance","volume":"188","author":"Li","year":"2003","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib69","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4161\/viru.2.5.16342","article-title":"The M protein of group A Streptococcus is a key virulence factor and a clinically relevant strain identification marker","volume":"2","author":"Metzgar","year":"2011","journal-title":"Virulence"},{"key":"10.1016\/j.isci.2024.111677_bib70","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.00101-13","article-title":"Disease manifestations and pathogenic mechanisms of group A Streptococcus","volume":"27","author":"Walker","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.isci.2024.111677_bib71","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1365-2958.2007.05841.x","article-title":"Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation","volume":"65","author":"Shannon","year":"2007","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib72","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tim.2010.02.007","article-title":"The streptococcal M protein: a highly versatile molecule","volume":"18","author":"Smeesters","year":"2010","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib73","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1172\/JCI3065","article-title":"Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection","volume":"102","author":"Ashbaugh","year":"1998","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2024.111677_bib74","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00413-12","article-title":"Human disease isolates of serotype M4 and M22 group A Streptococcus lack genes required for hyaluronic acid capsule biosynthesis","volume":"3","author":"Flores","year":"2012","journal-title":"mBio"},{"key":"10.1016\/j.isci.2024.111677_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00622-15","article-title":"Emergence of a new highly successful acapsular group A Streptococcus clade of genotype emm89 in the United Kingdom","volume":"6","author":"Turner","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.isci.2024.111677_bib76","series-title":"Streptococcus pyogenes: Basic Biology to Clinical Manifestations","article-title":"Streptococcus pyogenes Cell Wall and Surface Molecules: Capsule","author":"Wessels","year":"2022"},{"key":"10.1016\/j.isci.2024.111677_bib77","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/414648a","article-title":"Group A Streptococcus tissue invasion by CD44-mediated cell signalling","volume":"414","author":"Cywes","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.111677_bib78","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1016\/j.celrep.2019.11.001","article-title":"Group A streptococcal S protein utilizes red blood cells as immune camouflage and is a critical determinant for immune evasion","volume":"29","author":"Wierzbicki","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2024.111677_bib79","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01580-20","article-title":"T4 pili promote colonization and immune evasion phenotypes of nonencapsulated M4 Streptococcus pyogenes","volume":"11","author":"Chen","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.isci.2024.111677_bib80","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/infdis\/166.1.31","article-title":"Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988\u20131989","volume":"166","author":"Holm","year":"1992","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib81","doi-asserted-by":"crossref","first-page":"7676","DOI":"10.1073\/pnas.90.16.7676","article-title":"Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes","volume":"90","author":"Kapur","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.111677_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108515","article-title":"The proinflammatory cytokine IL-36\u03b3 is a global discriminator of harmless microbes and invasive pathogens within epithelial tissues","volume":"33","author":"Macleod","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2024.111677_bib83","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1128\/iai.64.11.4744-4750.1996","article-title":"Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease","volume":"64","author":"Burns","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2024.111677_bib84","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/pathogens10060776","article-title":"Streptococcus pyogenes (\u201cgroup A Streptococcus\u201d), a highly adapted human pathogen\u2014potential implications of its virulence regulation for epidemiology and disease management","volume":"10","author":"Siemens","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.isci.2024.111677_bib85","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CMR.13.3.470","article-title":"Pathogenesis of group A streptococcal infections","volume":"13","author":"Cunningham","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.isci.2024.111677_bib86","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.1074\/jbc.M704821200","article-title":"Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity","volume":"283","author":"Terao","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.111677_bib87","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2249784","article-title":"RopB-regulated SpeB cysteine protease degrades extracellular vesicles-associated streptolysin O and bacterial proteins from group A Streptococcus","volume":"14","author":"Chiang-Ni","year":"2023","journal-title":"Virulence"},{"key":"10.1016\/j.isci.2024.111677_bib88","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01680-24","article-title":"Seneca Valley virus circumvents Gasdermin A-mediated inflammation by targeting the pore-formation domain for cleavage","volume":"15","author":"Yin","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.isci.2024.111677_bib89","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0929-6646(08)60112-6","article-title":"Effects of streptococcal pyrogenic exotoxin B on pathogenesis of Streptococcus pyogenes","volume":"107","author":"Chiang-Ni","year":"2008","journal-title":"J.\u00a0Formos. Med. Assoc."},{"key":"10.1016\/j.isci.2024.111677_bib90","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/iai.47.1.52-60.1985","article-title":"Mechanism of membrane damage by streptolysin-O","volume":"47","author":"Bhakdi","year":"1985","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2024.111677_bib91","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0041-0101(01)00155-6","article-title":"The family of thiol-activated, cholesterol-binding cytolysins","volume":"39","author":"Palmer","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.isci.2024.111677_bib92","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1074\/jbc.M804632200","article-title":"Streptolysin O promotes group A Streptococcus immune evasion by accelerated macrophage apoptosis","volume":"284","author":"Timmer","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.111677_bib93","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1574-6968.1995.tb07538.x","article-title":"NAD+-glycohydrolase productivity of haemolytic streptococci assayed by a simple fluorescent method and its relation to T serotype","volume":"128","author":"Karasawa","year":"1995","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.isci.2024.111677_bib94","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01690-14","article-title":"Streptolysin O and NAD-glycohydrolase prevent phagolysosome acidification and promote group A Streptococcus survival in macrophages","volume":"5","author":"Bastiat-Sempe","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.isci.2024.111677_bib95","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01974-20","article-title":"Intracellular Group A Streptococcus induces Golgi fragmentation to impair host defenses through Streptolysin O and NAD-glycohydrolase","volume":"12","author":"Nozawa","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.isci.2024.111677_bib96","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s42003-023-04502-0","article-title":"Structural basis underlying the synergism of NADase and SLO during group A Streptococcus infection","volume":"6","author":"Tsai","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.isci.2024.111677_bib97","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.micro.55.1.77","article-title":"Toxic shock syndrome and bacterial superantigens: an update","volume":"55","author":"McCormick","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib98","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jinf.2019.02.005","article-title":"Identification of two new core chromosome-encoded superantigens in Streptococcus pyogenes; speQ and speR","volume":"78","author":"Reglinski","year":"2019","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.isci.2024.111677_bib99","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.189.1.89","article-title":"Identification and characterization of novel superantigens from Streptococcus pyogenes","volume":"189","author":"Proft","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2024.111677_bib100","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/323443","article-title":"Evidence for superantigen involvement in severe group a streptococcal tissue infections","volume":"184","author":"Norrby-Teglund","year":"2001","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib101","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1038\/s41467-020-18700-5","article-title":"Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes","volume":"11","author":"Brouwer","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.111677_bib102","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0140-6736(05)65800-X","article-title":"Detection of circulating bacterial superantigen and lymphotoxin-a in patients with streptococcal toxic-shock syndrome","volume":"348","author":"Sriskandan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2024.111677_bib103","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/432485","article-title":"Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes","volume":"192","author":"Edwards","year":"2005","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib104","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.chom.2008.07.002","article-title":"The IL-8 protease SpyCEP\/ScpC of group A Streptococcus promotes resistance to neutrophil killing","volume":"4","author":"Zinkernagel","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2024.111677_bib105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1086\/603541","article-title":"Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection","volume":"200","author":"Turner","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib106","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1073\/pnas.0406641102","article-title":"Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response","volume":"102","author":"Sumby","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.111677_bib107","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1099\/mic.0.000612","article-title":"The DNases of pathogenic Lancefield streptococci","volume":"164","author":"Remmington","year":"2018","journal-title":"Microbiology"},{"key":"10.1016\/j.isci.2024.111677_bib108","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jid.2018.11.027","article-title":"Group A streptococcal DNase Sda1 impairs plasmacytoid dendritic cells\u2019 type 1 interferon response","volume":"139","author":"Keller","year":"2019","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.isci.2024.111677_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002736","article-title":"DNase Sda1 allows invasive M1T1 Group A Streptococcus to prevent TLR9-dependent recognition","volume":"8","author":"Uchiyama","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2024.111677_bib110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cub.2005.12.039","article-title":"DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps","volume":"16","author":"Buchanan","year":"2006","journal-title":"Curr. Biol."},{"key":"10.1016\/j.isci.2024.111677_bib111","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/377100","article-title":"Plasminogen enhances virulence of group A streptococci by streptokinase-dependent and streptokinase-independent mechanisms","volume":"188","author":"Khil","year":"2003","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.667554","article-title":"Group A Streptococcus-induced activation of human plasminogen is required for keratinocyte wound retraction and rapid clot dissolution","volume":"8","author":"Vu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.isci.2024.111677_bib113","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1084\/jem.20190293","article-title":"Streptococcus pyogenes evades adaptive immunity through specific IgG glycan hydrolysis","volume":"216","author":"Naegeli","year":"2019","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2024.111677_bib114","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1093\/cid\/cis629","article-title":"Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America","volume":"55","author":"Shulman","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib115","doi-asserted-by":"crossref","first-page":"e956","DOI":"10.1542\/peds.2014-0605","article-title":"Bacterial prevalence and antimicrobial prescribing trends for acute respiratory tract infections","volume":"134","author":"Kronman","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.isci.2024.111677_bib116","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpedi.153.7.681","article-title":"Management of sore throats in children: a cost-effectiveness analysis","volume":"153","author":"Tsevat","year":"1999","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.isci.2024.111677_bib117","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0196-0644(95)70300-4","article-title":"Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment","volume":"25","author":"Pichichero","year":"1995","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.isci.2024.111677_bib118","doi-asserted-by":"crossref","first-page":"e557","DOI":"10.1542\/peds.2009-2648","article-title":"Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis","volume":"126","author":"Shaikh","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.isci.2024.111677_bib119","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jpeds.2011.09.011","article-title":"Accuracy and precision of the signs and symptoms of streptococcal pharyngitis in children: a systematic review","volume":"160","author":"Shaikh","year":"2012","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.isci.2024.111677_bib120","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0022-3476(85)80228-6","article-title":"Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis","volume":"106","author":"Randolph","year":"1985","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.isci.2024.111677_bib121","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00006454-198707000-00004","article-title":"Adverse and beneficial effects of immediate treatment of Group A beta-hemolytic streptococcal pharyngitis with penicillin","volume":"6","author":"Pichichero","year":"1987","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.isci.2024.111677_bib122","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00006565-199910000-00011","article-title":"Detection of group A streptococci in children under 3 years of age with pharyngitis","volume":"15","author":"Woods","year":"1999","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.isci.2024.111677_bib123","first-page":"386","article-title":"The latent period before the onset of acute rheumatic fever","volume":"34","author":"Rammelkamp","year":"1961","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.isci.2024.111677_bib124","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","article-title":"Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association","volume":"131","author":"Gewitz","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2024.111677_bib125","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jpeds.2008.05.044","article-title":"Differentiation of post-streptococcal reactive arthritis from acute rheumatic fever","volume":"153","author":"Barash","year":"2008","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.isci.2024.111677_bib126","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/art.24401","article-title":"No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis","volume":"60","author":"van Bemmel","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.isci.2024.111677_bib127","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/003655400459504","article-title":"Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum","volume":"32","author":"Svensson","year":"2000","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib128","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1172\/JCI106135","article-title":"Attack rates of acute nephritis after type 49 streptococcal infection of the skin and of the respiratory tract","volume":"48","author":"Anthony","year":"1969","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2024.111677_bib129","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00005792-195512000-00002","article-title":"Epidemic acute nephritis: studies on etiology, natural history and prevention","volume":"34","author":"Stetson","year":"1955","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.isci.2024.111677_bib130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-79-4-492","article-title":"Occurrence and nature of glomerular lesions after group A streptococci infections in children","volume":"79","author":"Sagel","year":"1973","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.isci.2024.111677_bib131","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1097\/00007611-197710000-00015","article-title":"Acute glomerulonephritis in children: a review of 153 cases","volume":"70","author":"Sanjad","year":"1977","journal-title":"South. Med. J."},{"key":"10.1016\/j.isci.2024.111677_bib132","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00005792-197111000-00001","article-title":"Clinico-pathologic correlations in acute poststreptococcal glomerulonephritis. A correlation between renal functions, morphologic damage and clinical course of 46 children with acute poststreptococcal glomerulonephritis","volume":"50","author":"Lewy","year":"1971","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.isci.2024.111677_bib133","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jpeds.2011.07.012","article-title":"Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections","volume":"160","author":"Murphy","year":"2012","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.isci.2024.111677_bib134","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/ajp.155.2.264","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases","volume":"155","author":"Swedo","year":"1998","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.isci.2024.111677_bib135","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1542\/peds.113.4.907","article-title":"The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction","volume":"113","author":"Swedo","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.isci.2024.111677_bib136","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0006-3223(03)00704-2","article-title":"Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics","volume":"55","author":"Murphy","year":"2004","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.isci.2024.111677_bib137","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00006454-198607000-00012","article-title":"Peritonsillitis: abscess or cellulitis?","volume":"5","author":"Shoemaker","year":"1986","journal-title":"Pediatr. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib138","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/lio2.659","article-title":"Severe acute otitis media and mastoiditis caused by group A beta-hemolytic streptococcus","volume":"6","author":"Laakso","year":"2021","journal-title":"Laryngoscope Investig. Otolaryngol."},{"key":"10.1016\/j.isci.2024.111677_bib139","article-title":"Tonsillitis and Sinusitis: A Narrative Review of Pathogenesis, Diagnosis, and Management","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.isci.2024.111677_bib140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/clinids\/15.2.277","article-title":"Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings","volume":"15","author":"Schwartz","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib141","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3201\/eid0103.950301","article-title":"Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment","volume":"1","author":"Stevens","year":"1995","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib142","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1056\/NEJMra1600673","article-title":"Necrotizing Soft-Tissue Infections","volume":"377","author":"Stevens","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.111677_bib143","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S1473-3099(22)00583-7","article-title":"Necrotising soft-tissue infections","volume":"23","author":"Hua","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib144","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciu444","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib145","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00000658-199505000-00013","article-title":"Determinants of mortality for necrotizing soft-tissue infections","volume":"221","author":"McHenry","year":"1995","journal-title":"Ann. Surg."},{"key":"10.1016\/j.isci.2024.111677_bib146","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00005792-198903000-00002","article-title":"The Lemierre syndrome: suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection","volume":"68","author":"Sinave","year":"1989","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.isci.2024.111677_bib147","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00005792-200211000-00006","article-title":"The evolution of Lemierre syndrome: report of 2 cases and review of the literature","volume":"81","author":"Chirinos","year":"2002","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.isci.2024.111677_bib148","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f5806","article-title":"Clinical score and rapid antigen detection test to guide antibiotic use for sore throats: randomised controlled trial of PRISM (primary care streptococcal management)","volume":"347","author":"Little","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.isci.2024.111677_bib149","article-title":"Antibiotics for sore throat","volume":"2013","author":"Spinks","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.isci.2024.111677_bib150","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0002-9343(51)90274-4","article-title":"Effect in penicillin and aureomycin on the natural course of streptococcal tonsillitis and pharyngitis","volume":"10","author":"Brink","year":"1951","journal-title":"Am. J. Med."},{"key":"10.1016\/j.isci.2024.111677_bib151","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/CIRCULATIONAHA.114.008720","article-title":"Global and regional patterns in cardiovascular mortality from 1990 to 2013","volume":"132","author":"Roth","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2024.111677_bib152","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/pgmj.46.541.641","article-title":"Streptococcal skin infection and acute glomerulonephritis","volume":"46","author":"Dillon","year":"1970","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.isci.2024.111677_bib153","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00006454-199904000-00003","article-title":"Evaluating the use of penicillin to control outbreaks of acute poststreptococcal glomerulonephritis","volume":"18","author":"Johnston","year":"1999","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.isci.2024.111677_bib154","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/clinids\/14.1.2","article-title":"Invasive group A streptococcus infections","volume":"14","author":"Stevens","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0934-8840(11)80026-5","article-title":"Streptococcal toxic shock syndrome","volume":"272","author":"K\u00f6hler","year":"1990","journal-title":"Zentralbl. Bakteriol."},{"key":"10.1016\/j.isci.2024.111677_bib156","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/archinte.1985.00360060076010","article-title":"Streptococcal myositis","volume":"145","author":"Adams","year":"1985","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.isci.2024.111677_bib157","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7326\/0003-4819-108-5-772_2","article-title":"Streptococcus pyogenes and the toxic shock syndrome","volume":"108","author":"Hr\u00edbalov\u00e1","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.isci.2024.111677_bib158","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM198911303212212","article-title":"Group A streptococcal infections and a toxic shock-like syndrome","volume":"321","author":"Drabick","year":"1989","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.111677_bib159","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/cid\/ciy401","article-title":"Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis","volume":"67","author":"Parks","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib160","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1086\/519936","article-title":"Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden","volume":"45","author":"Darenberg","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198907063210101","article-title":"Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A","volume":"321","author":"Stevens","year":"1989","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.111677_bib162","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3109\/00365549209054644","article-title":"Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects","volume":"24","author":"Stegmayr","year":"1992","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib163","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/JCM.43.4.1789-1796.2005","article-title":"Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study","volume":"43","author":"Ekelund","year":"2005","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib164","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.109.191959","volume":"119","author":"Gerber","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2024.111677_bib165","article-title":"A brief review on Group A Streptococcus pathogenesis and vaccine development","volume":"8","author":"Castro","year":"2021","journal-title":"R.\u00a0Soc. Open Sci."},{"key":"10.1016\/j.isci.2024.111677_bib166","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/INF.0000000000001442","article-title":"Macrolide and clindamycin resistance in group a streptococci isolated from children with pharyngitis","volume":"36","author":"DeMuri","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.isci.2024.111677_bib167","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1586\/14760584.2015.1081817","article-title":"Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci","volume":"14","author":"Good","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.isci.2024.111677_bib168","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/14760584.2016.1116946","article-title":"Development of Group A streptococcal vaccines: an unmet global health need","volume":"15","author":"Sheel","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.isci.2024.111677_bib169","doi-asserted-by":"crossref","first-page":"B216","DOI":"10.1016\/j.vaccine.2012.09.045","article-title":"Group A streptococcal vaccines: paving a path for accelerated development","volume":"31","author":"Dale","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2024.111677_bib170","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.vaccine.2014.05.017","article-title":"Working towards a group A streptococcal vaccine: report of a collaborative Trans-Tasman workshop","volume":"32","author":"Moreland","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2024.111677_bib171","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.vaccine.2013.01.019","article-title":"Potential coverage of a multivalent M protein-based group A streptococcal vaccine","volume":"31","author":"Dale","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2024.111677_bib172","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.4049\/jimmunol.1202333","article-title":"Long-term antibody memory induced by synthetic peptide vaccination is protective against Streptococcus pyogenes infection and is independent of memory T\u00a0cell help","volume":"190","author":"Pandey","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2024.111677_bib173","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7774\/cevr.2016.5.2.101","article-title":"Accelerating the development of a group A Streptococcus vaccine: an urgent public health need","volume":"5","author":"Excler","year":"2016","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.isci.2024.111677_bib174","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.4049\/jimmunol.1501994","article-title":"Combinatorial synthetic peptide vaccine strategy protects against hypervirulent CovR\/S mutant streptococci","volume":"196","author":"Pandey","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.isci.2024.111677_bib175","doi-asserted-by":"crossref","first-page":"34063","DOI":"10.18632\/oncotarget.6140","article-title":"The quest for GAS vaccine","volume":"6","author":"Pandey","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2024.111677_bib176","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/vaccines7030058","article-title":"Recent advances in the development of peptide vaccines and their delivery systems against group a streptococcus","volume":"7","author":"Azuar","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.isci.2024.111677_bib177","article-title":"The structure and function of serum opacity factor: a unique streptococcal virulence determinant that targets high-density lipoproteins","volume":"2010","author":"Courtney","year":"2010","journal-title":"J.\u00a0Biomed. Biotechnol."},{"key":"10.1016\/j.isci.2024.111677_bib178","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1128\/IAI.00295-10","article-title":"Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine","volume":"78","author":"Fritzer","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2024.111677_bib179","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3390\/molecules23071712","article-title":"Recent advances in the synthesis of glycoconjugates for vaccine development","volume":"23","author":"Colombo","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2024.111677_bib180","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.015693","article-title":"Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case","volume":"11","author":"Bensi","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.isci.2024.111677_bib181","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00693-19","article-title":"An experimental group A Streptococcus vaccine that reduces pharyngitis and tonsillitis in a nonhuman primate model","volume":"10","author":"Rivera-Hernandez","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.isci.2024.111677_bib182","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.actbio.2018.09.037","article-title":"Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus","volume":"80","author":"Nevagi","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.isci.2024.111677_bib183","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1021\/acs.jmedchem.0c01660","article-title":"Poly (hydrophobic amino acid)-based self-adjuvanting nanoparticles for Group A Streptococcus vaccine delivery","volume":"64","author":"Azuar","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.isci.2024.111677_bib184","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7774\/cevr.2017.6.1.45","article-title":"Trivalent M-related protein as a component of\u00a0next generation group A streptococcal vaccines","volume":"6","author":"Courtney","year":"2017","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.isci.2024.111677_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113194","article-title":"An eight-plex immunoassay for Group A streptococcus serology and vaccine development","volume":"500","author":"Whitcombe","year":"2022","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.isci.2024.111677_bib186","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1016\/j.vaccine.2016.03.073","article-title":"Status of research and development of vaccines for Streptococcus pyogenes","volume":"34","author":"Steer","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2024.111677_bib187","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41588-019-0417-8","article-title":"Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics","volume":"51","author":"Davies","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2024.111677_bib188","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0045-2018","article-title":"Molecular mimicry, autoimmunity, and infection: The cross-reactive antigens of group A Streptococci and their Sequelae","volume":"7","author":"Cunningham","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2024.111677_bib189","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/cid\/ciy1143","article-title":"The path to group A Streptococcus vaccines: World Health Organization research and development technology roadmap and preferred product characteristics","volume":"69","author":"Vekemans","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib190","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00647-18","article-title":"A controlled human infection model of group A Streptococcus pharyngitis: which strain and why?","volume":"4","author":"Osowicki","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.isci.2024.111677_bib191","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.169.1.269","article-title":"Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever","volume":"169","author":"Bessen","year":"1989","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.isci.2024.111677_bib192","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.41.3.937-942.2003","article-title":"Epidemiologic analysis of invasive and noninvasive group A streptococcal isolates in Hong Kong","volume":"41","author":"Ho","year":"2003","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib193","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s10096-004-1147-z","article-title":"Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992\u20131996","volume":"23","author":"Vlaminckx","year":"2004","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib194","series-title":"Acute rheumatic fever and rheumatic heart disease","first-page":"275","article-title":"Group A Streptococcus vaccines","author":"Osowicki","year":"2021"},{"key":"10.1016\/j.isci.2024.111677_bib195","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1128\/JCM.41.11.4941-4949.2003","article-title":"Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants","volume":"41","author":"Vlaminckx","year":"2003","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.isci.2024.111677_bib196","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/430618","article-title":"Genome sequence of a serotype M28 strain of group A Streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity","volume":"192","author":"Green","year":"2005","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib197","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1128\/IAI.01291-06","article-title":"Determination of the relationship between group A streptococcal genome content, M type, and toxic shock syndrome by a mixed genome microarray","volume":"75","author":"Vlaminckx","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2024.111677_bib198","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129417","article-title":"Serotype M3 and M28 group A streptococci have distinct capacities to evade neutrophil and TNF-\u03b1 responses and to invade soft tissues","volume":"10","author":"Stetzner","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.111677_bib199","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jmii.2021.09.008","article-title":"Attenuation of virulence in multiple serotypes (M1, M3, and M28) of group A Streptococcus after the loss of secreted esterase","volume":"55","author":"Zhang","year":"2022","journal-title":"J.\u00a0Microbiol. Immunol. Infect."},{"key":"10.1016\/j.isci.2024.111677_bib200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3201\/eid1101.030651","article-title":"Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal, 1995\u20132002","volume":"11","author":"Hollm-Delgado","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib201","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02294-17","article-title":"Virulence role of the GlcNAc side chain of the Lancefield cell wall carbohydrate antigen in non-M1-serotype group A Streptococcus","volume":"9","author":"Henningham","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.isci.2024.111677_bib202","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/infdis\/171.4.871","article-title":"Distribution of fibronectin-binding proteins among group A streptococci of different M types","volume":"171","author":"Natanson","year":"1995","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib203","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1128\/IAI.00180-15","article-title":"Streptococcus pyogenes triggers activation of the human contact system by streptokinase","volume":"83","author":"Nitzsche","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2024.111677_bib204","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1096\/fj.06-5804fje","article-title":"Trigger for group A streptococcal M1T1 invasive disease","volume":"20","author":"Cole","year":"2006","journal-title":"Faseb. J."},{"key":"10.1016\/j.isci.2024.111677_bib205","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/mpat.1993.1083","article-title":"A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin","volume":"15","author":"Kapur","year":"1993","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.isci.2024.111677_bib206","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/cid\/cis847","article-title":"Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America","volume":"55","author":"Shulman","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2024.111677_bib207","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jtcvs.2014.05.014","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"148","author":"Nishimura","year":"2014","journal-title":"J.\u00a0Thorac. Cardiovasc. Surg."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224029043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224029043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T00:16:17Z","timestamp":1761437777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224029043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":207,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2589004224029043"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.111677","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The burden of group A Streptococcus (GAS) infections: The challenge continues in the twenty-first century","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.111677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111677"}}